Last reviewed · How we verify

NCT04457895: SKYPE2

A Randomized, Open-labelled, Controlled Trial Evaluating the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.

Recruiting now NA Last updated 2 June 2026
What this trial tests

NA trial testing educational yoga program in Breast Cancer in 108 participants. Currently enrolling.

Timeline
11 February 2021
Primary endpoint
1 August 2028
1 August 2028

Quick facts

Lead sponsorInstitut du Cancer de Montpellier - Val d'Aurelle
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment108
Start date11 February 2021
Primary completion1 August 2028
Estimated completion1 August 2028
Sites7 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle — full company profile →

Who can join

Adults 18 to 99, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

As much as 50% of patients treated with hormonotherapy (HT) for breast cancer (BC) suffer from osteoarticular pain during treatment. Secondary effects have become a real issue because of their consequences on the patients' quality of life, but also on treatment efficacy and survival when they induce dose reduction or premature withdrawal of treatment. Additional medicines (acupuncture, hypnosis, yoga) have become more and more popular these last years. 48 to 80% of patients with BC eventually choose them. A review comparing efficacy of various therapies to decrease osteoarticular pain concludes to a highest efficacy of anti-inflammatory treatments, paracetamol and yoga. It thus appears innovative to complete this care with a patient educational project (PEP) in postural yoga instructed by a trained physical therapist, which will enable patients to practice yoga postures at home by themselves. The investigators conducted a pilot study "SKYPE" with 24 algic patients treated with HT after BC, whose results are very promising. The investigators now propose in the continuity of the pilot study a multicenter randomized controlled study comparing the efficacy of SKYPE care on pain reduction, an educative care combining physical therapy and yoga, to a control group in patients treated with HT for a BC with osteoarticular and/or musculoskeletal pain. Furthermore, in order to examine whether yoga interventions may influence inflammation through their effects on the level of a wide range of pro- and anti-inflammatory cytokines (30), the investigators will Change in circulating cytokines' level between baseline level (T0) and post-treatment level (T2) in both groups will be analyzed and if so correlation will be established.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility Study.
    Faravel K, Huteau ME, Jarlier M, de Forges H, et al · · 2021 · cited 4× · PMID 34939444 · DOI 10.1177/15347354211063791
  2. Yoga for fatigue in people with cancer.
    Messer S, Oeser A, Wagner C, Wender A, et al · · 2025 · cited 2× · PMID 40421669 · DOI 10.1002/14651858.cd015520
  3. Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2).
    Faravel K, Jarlier M, Meignant L, Thomaso M, et al · · 2024 · PMID 38191246 · DOI 10.1136/bmjopen-2023-075378

Verify or expand the search:

Other trials of educational yoga program

Trials testing the same drug.

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Institut du Cancer de Montpellier - Val d'Aurelle trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457895.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing